178 related articles for article (PubMed ID: 10998074)
1. Homocysteine: an emergent cardiovascular risk factor?
Medina MA; Amores-Sánchez MI
Eur J Clin Invest; 2000 Sep; 30(9):754-62. PubMed ID: 10998074
[TBL] [Abstract][Full Text] [Related]
2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
3. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
4. Roles of homocysteine in cell metabolism: old and new functions.
Medina M; Urdiales JL; Amores-Sánchez MI
Eur J Biochem; 2001 Jul; 268(14):3871-82. PubMed ID: 11453979
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
6. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia and cardiovascular disease in animal model.
Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y
Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979
[TBL] [Abstract][Full Text] [Related]
8. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients.
Socha MW; Polakowska MJ; Socha-Urbanek K; Fiedor P
Ann Transplant; 1999; 4(1):11-9. PubMed ID: 10850596
[TBL] [Abstract][Full Text] [Related]
10. [Homocysteine and rheumatic disease].
Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine--is it still an important risk factor for cardiovascular disease?
Cybulska B; Kłosiewicz-Latoszek L
Kardiol Pol; 2015; 73(11):1092-6. PubMed ID: 26726726
[No Abstract] [Full Text] [Related]
12. Homocysteine in cardiovascular disease: a culprit or an innocent bystander?
Kothekar MA
Indian J Med Sci; 2007 Jun; 61(6):361-71. PubMed ID: 17558103
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
[TBL] [Abstract][Full Text] [Related]
14. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review.
Chrysant SG; Chrysant GS
Expert Rev Cardiovasc Ther; 2018 Aug; 16(8):559-565. PubMed ID: 29979619
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540
[TBL] [Abstract][Full Text] [Related]
16. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
Alemán G; Tovar AR; Torres N
Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine and cardiovascular disease: current evidence and future prospects.
Mangoni AA; Jackson SH
Am J Med; 2002 May; 112(7):556-65. PubMed ID: 12015248
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes].
Malinowska J; Nowak P; Olas B
Pol Merkur Lekarski; 2009 Nov; 27(161):413-8. PubMed ID: 19999808
[TBL] [Abstract][Full Text] [Related]
19. [Homocysteine metabolism].
Hashimoto T; Shinohara Y; Hasegawa H
Yakugaku Zasshi; 2007 Oct; 127(10):1579-92. PubMed ID: 17917419
[TBL] [Abstract][Full Text] [Related]
20. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
Caramia G; Belardinelli R
Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
